Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
Afon Technology is a leader in advanced medical technology focused on transforming diabetes care. Brad Love and Dan Fowles discuss how the company uses big data to create personalised health solutions that can significantly impact the lives of millions.
Regular foot check-ups are critical for mitigating foot problems in people with diabetes; Lorna Rothery spoke to the podiatry team at Mid Yorkshire Teaching Hospital about the risk factors for and prevention of diabetic foot problems.
Sabih Chaudhry, CEO of Afon Technology Ltd, takes us on an exciting journey through the groundbreaking innovation of GlucowearTM – revolutionising non-invasive blood glucose monitoring.
Researchers at University College London (UCL) have developed a miniature scanner that could transform the way doctors diagnose and manage diseases such as cancer, diabetes, and arthritis.
Dr Rayaz A Malik, Professor of Medicine at Weill Cornell Medicine-Qatar, discusses the challenges and impact of misdiagnosis and late diagnosis in type 1 diabetes.
Sabih Chaudhry, CEO of Afon Technology Ltd, describes the company’s innovative Glucowear™ — the world’s first non-invasive, real-time, and continuous blood glucose sensor.
Beyond the impact of the COVID-19 pandemic on routine care, other factors impact the physical and mental wellbeing of people with diabetes. Lorna Rothery spoke to Dr Mayank Patel, a consultant in diabetes at University Hospital Southampton and member of the DRWF editorial advisory board, about the importance of education in changing attitudes towards type 1 and type 2 diabetes stigma.
Researchers in Portugal look at the critical gaps in knowledge against type 2 diabetes (T2D) patients, potentially impacting their long-term health outcomes.
Diabetes represents a huge burden on health systems and sufferers, but accurately monitoring blood sugar levels could help people to take control of their health before more serious issues come to light.
35.3% of British adults are likely to have prediabetes. Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, argues that increased diabetes testing is needed to ensure 18 million people don’t go on to develop ‘full-blown’ diabetes.
